Clinical Trial Update: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating atorvastatin for microvascular endothelial function and Raynaud phenomenon in early diffuse cutaneous systemic sclerosis (scleroderm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Raynaud Phenomenon
• Scleroderma

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Robyn T. Domsic, MD, MPH | Conditions: Scleroderma | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12